2021 Predictions for Regenerative Medicine as the Pandemic Continues

January 29, 2021

While the pandemic continues to disrupt many industries, including regenerative medicineit’s not all bad news -- in fact, there are likely some bright spots ahead for the industry this year. 

In an article featured on Technology Network, Cryoport Systems CEO Mark Sawicki, Ph.D. predicts initial expectations for the regenerative medicine space in 2021. Sawicki outlines the clinical trial impact for cell and gene therapies, COVID-19's impact on vaccine development and cell and gene therapy distribution, and commercial activity and regulatory considerations within regenerative medicine.

Read the full article here.

Questions or comments? We welcome your feedback!

Email Us

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC